Interestingly, STAT3 knockdown in GSCs and conventional glioma cell lines coincided with the phenotypes described with SOX9 silencing of reduced self-renewing in vitro and decreased tumorigenic activity in vivo. This evidence concerns the gene SOX9 and glioma.